China enhances vaccine work; Almac facility gets FDA nod;

> Reumofan Plus USA and Reumofan USA is recalling Reumofan Plus Tablets, which it sells for muscle pain, because they contain undeclared APIs methocarbamol, dexamethasone, and diclofenac. Release

> DSM says its Belgium-based API business will begin selling active pharmaceutical ingredients manufactured by Indian API maker Indoco. Release

> The FDA has inspected an Almac lab at its Northern Ireland home of Craigavon, which the company says will support commercial launch of a couple of products in the U.S. Story

> A folding carton concept from Edelmann, the German manufacturer of board packaging, has been recognized again, picking up a Pharmapack Award. Item

> Synbiosis says the State Food and Drug Administration will add 25 of its automated colony counting and inhibition zone sizing systems to its facilities in Shanghai to boost productivity of vaccine and antibiotic testing at SFDA's labs. Item